Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Teva CEO Steps Down
Error: Contact form not found.
by JNS.org
Outgoing Teva CEO Shlomo Yanai (left) with NJ Governor Chris Christie. Photo: NJ Governor's Office.
The CEO of Israeli pharmaceutical company Teva left the company today, although the company reported a net revenue of $5.1 billion, up 25 percent in the corresponding quarter of 2011, reported Globes.
“It has been an immense privilege to lead Teva’s outstanding global team through such an exciting period. Together we turned Teva into a highly diversified global pharmaceutical company, with an expanded geographical footprint and additional lines of business,” said exiting CEO Shlomo Yanai.
As JointMedia News Service previously reported, Yanai will be replaced by new global CEO Dr. Jeremy Levin. The company had boasted a presence in 60 countries and employed about 40,000 employees in 2012, resulting in $16 billion in sales that year. Teva is especially known for manufacturing Copaxone, a revolutionary drug treating Multiple Sclerosis developed at the Weizman Institute of Science in Rehovot, Israel.
